Does ranolazine have a place in the treatment of acute coronary syndromes?
Publication
, Journal Article
Newby, LK; Peterson, ED
Published in: JAMA
April 25, 2007
Duke Scholars
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
April 25, 2007
Volume
297
Issue
16
Start / End Page
1823 / 1825
Location
United States
Related Subject Headings
- Ranolazine
- Piperazines
- Myocardial Infarction
- Humans
- General & Internal Medicine
- Enzyme Inhibitors
- Cardiovascular Agents
- Angina Pectoris
- Acetanilides
- 42 Health sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Newby, L. K., & Peterson, E. D. (2007). Does ranolazine have a place in the treatment of acute coronary syndromes? JAMA, 297(16), 1823–1825. https://doi.org/10.1001/jama.297.16.1823
Newby, L Kristin, and Eric D. Peterson. “Does ranolazine have a place in the treatment of acute coronary syndromes?” JAMA 297, no. 16 (April 25, 2007): 1823–25. https://doi.org/10.1001/jama.297.16.1823.
Newby LK, Peterson ED. Does ranolazine have a place in the treatment of acute coronary syndromes? JAMA. 2007 Apr 25;297(16):1823–5.
Newby, L. Kristin, and Eric D. Peterson. “Does ranolazine have a place in the treatment of acute coronary syndromes?” JAMA, vol. 297, no. 16, Apr. 2007, pp. 1823–25. Pubmed, doi:10.1001/jama.297.16.1823.
Newby LK, Peterson ED. Does ranolazine have a place in the treatment of acute coronary syndromes? JAMA. 2007 Apr 25;297(16):1823–1825.
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
April 25, 2007
Volume
297
Issue
16
Start / End Page
1823 / 1825
Location
United States
Related Subject Headings
- Ranolazine
- Piperazines
- Myocardial Infarction
- Humans
- General & Internal Medicine
- Enzyme Inhibitors
- Cardiovascular Agents
- Angina Pectoris
- Acetanilides
- 42 Health sciences